Dr. Hönle AG (HNL) — Capital Reinvestment Ratio
Dr. Hönle AG (HNL) has a Capital Reinvestment Ratio of 0.12x as of June 2026, meaning it reinvests 0% of its operating cash flow (€2.20 Million) in capital expenditures (€266.00K). Check Dr. Hönle AG (HNL) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dr. Hönle AG Capital Reinvestment Ratio (2014–2025)
This chart tracks Dr. Hönle AG's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see HNL cash generation efficiency.
Annual Capital Reinvestment Ratio for Dr. Hönle AG (2014–2025)
Year-by-year Capital Reinvestment Ratio for Dr. Hönle AG from 2014 to 2025. See Dr. Hönle AG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €4.99 Million | €1.90 Million | ▲ +0.5% |
| 2024 | 0.38x | €5.53 Million | €2.09 Million | ▼ -59.4% |
| 2023 | 0.93x | €3.14 Million | €2.93 Million | ▼ -93.8% |
| 2021 | 15.12x | €1.13 Million | €17.09 Million | ▲ +262.3% |
| 2020 | 4.17x | €7.23 Million | €30.20 Million | ▲ +266.5% |
| 2019 | 1.14x | €16.92 Million | €19.28 Million | ▲ +160.8% |
| 2018 | 0.44x | €24.22 Million | €10.58 Million | ▼ -46.4% |
| 2017 | 0.81x | €6.58 Million | €5.36 Million | ▲ +41.3% |
| 2016 | 0.58x | €8.63 Million | €4.98 Million | ▲ +147.3% |
| 2015 | 0.23x | €9.16 Million | €2.14 Million | ▼ -43.4% |
| 2014 | 0.41x | €7.49 Million | €3.08 Million | — |